Xuan Marian Thai

Array ( [id] => 8174222 [patent_doc_number] => 20120108797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'TARGETED BINDING AGENTS DIRECTED TO UPAR AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/193167 [patent_app_country] => US [patent_app_date] => 2011-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47416 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108797.pdf [firstpage_image] =>[orig_patent_app_number] => 13193167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977039 [patent_doc_number] => 09023346 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Method of treating stroke with tenecteplase' [patent_app_type] => utility [patent_app_number] => 13/189413 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10567 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13189413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7662736 [patent_doc_number] => 20110312005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'Enzymatic modification of cell-surface H antigen by glycosyltransferases' [patent_app_type] => utility [patent_app_number] => 13/137096 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7263 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20110312005.pdf [firstpage_image] =>[orig_patent_app_number] => 13137096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733275 [patent_doc_number] => 20120015867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'THERAPEUTIC PEPTIDES AND METHOD' [patent_app_type] => utility [patent_app_number] => 13/181323 [patent_app_country] => US [patent_app_date] => 2011-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22575 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015867.pdf [firstpage_image] =>[orig_patent_app_number] => 13181323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138559 [patent_doc_number] => 20120093818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/174423 [patent_app_country] => US [patent_app_date] => 2011-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 153 [patent_figures_cnt] => 153 [patent_no_of_words] => 78137 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13174423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794132 [patent_doc_number] => 09403882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Sulfation of Wnt pathway proteins' [patent_app_type] => utility [patent_app_number] => 13/170634 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21627 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13170634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335129 [patent_doc_number] => 20120201835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'ANTIBODIES SPECIFIC FOR DKK-1' [patent_app_type] => utility [patent_app_number] => 13/169523 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20513 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13169523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731537 [patent_doc_number] => 20120014952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/162479 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37131 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014952.pdf [firstpage_image] =>[orig_patent_app_number] => 13162479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733287 [patent_doc_number] => 20120015871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/162423 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37129 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015871.pdf [firstpage_image] =>[orig_patent_app_number] => 13162423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733288 [patent_doc_number] => 20120015872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPLEMENT RECEPTOR 2 TARGETED COMPLEMENT MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/162434 [patent_app_country] => US [patent_app_date] => 2011-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 37438 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015872.pdf [firstpage_image] =>[orig_patent_app_number] => 13162434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8065929 [patent_doc_number] => 20110244053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Use a goat serum for veterinary treatment' [patent_app_type] => utility [patent_app_number] => 13/134512 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2832 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244053.pdf [firstpage_image] =>[orig_patent_app_number] => 13134512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9008941 [patent_doc_number] => 08524235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-03 [patent_title] => 'Method for treating coronary artery disease using antibody binding human protein tyrosine phosphatase beta(HPTPbeta)' [patent_app_type] => utility [patent_app_number] => 13/115180 [patent_app_country] => US [patent_app_date] => 2011-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13334 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13115180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791666 [patent_doc_number] => 20130108635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF MATRIX MINERALIZATION DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/695127 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 19991 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903650 [patent_doc_number] => 20130171153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'PROTEINS THAT BIND PI16 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/640356 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 49439 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7650891 [patent_doc_number] => 20110300160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'SULFATION OF WNT PATHWAY PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/088059 [patent_app_country] => US [patent_app_date] => 2011-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18049 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0300/20110300160.pdf [firstpage_image] =>[orig_patent_app_number] => 13088059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7509970 [patent_doc_number] => 20110256137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING A BISPECIFIC ANTIBODY FOR EPCAM' [patent_app_type] => utility [patent_app_number] => 13/079453 [patent_app_country] => US [patent_app_date] => 2011-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 72 [patent_figures_cnt] => 72 [patent_no_of_words] => 18551 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256137.pdf [firstpage_image] =>[orig_patent_app_number] => 13079453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066163 [patent_doc_number] => 20110243948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Monoclonal Antibodies Against ANGPTL3' [patent_app_type] => utility [patent_app_number] => 13/073617 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 36282 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243948.pdf [firstpage_image] =>[orig_patent_app_number] => 13073617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066145 [patent_doc_number] => 20110243952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'COMPOUND AND METHOD FOR REGULATING PLASMINOGEN ACTIVATION AND CELL MIGRATION' [patent_app_type] => utility [patent_app_number] => 13/073946 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 18535 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243952.pdf [firstpage_image] =>[orig_patent_app_number] => 13073946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8409961 [patent_doc_number] => 08273355 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Hepatocyte growth factor (HGF) binding proteins' [patent_app_type] => utility [patent_app_number] => 13/051481 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34296 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13051481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487415 [patent_doc_number] => 20110236377 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Hepatocyte Growth Factor (HGF) Binding Proteins' [patent_app_type] => utility [patent_app_number] => 13/051474 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34247 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236377.pdf [firstpage_image] =>[orig_patent_app_number] => 13051474 [rel_patent_id] =>[rel_patent_doc_number] =>)